These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35021944)

  • 1. Effects of nanocurcumin supplementation on T-helper 17 cells inflammatory response in patients with Behcet's disease: a randomized controlled trial.
    Farzaneh R; Khabbazi A; Soltani-Zangbar MS; Abbasian S; Malek Mahdavi A; Motavalli R; Yousefi M
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):206-215. PubMed ID: 35021944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocurcumin supplementation ameliorates Behcet's disease by modulating regulatory T cells: A randomized, double-blind, placebo-controlled trial.
    Abbasian S; Soltani-Zangbar MS; Khabbazi A; Farzaneh R; Malek Mahdavi A; Motavalli R; Hajialilo M; Yousefi M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108237. PubMed ID: 34653732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function.
    Hajialilo M; Dolati S; Abdolmohammadi-Vahid S; Ahmadi M; Kamrani A; Eghbal-Fard S; Ghassembaglou A; Valizadeh A; Shenas MHM; Aghebati-Maleki L; Kafil HS; Mehdizadeh A; Yousefi M
    J Cell Biochem; 2019 Jul; 120(7):12027-12038. PubMed ID: 30805973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
    Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
    Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.
    Tahmasebi S; El-Esawi MA; Mahmoud ZH; Timoshin A; Valizadeh H; Roshangar L; Varshoch M; Vaez A; Aslani S; Navashenaq JG; Aghebati-Maleki L; Ahmadi M
    J Cell Physiol; 2021 Jul; 236(7):5325-5338. PubMed ID: 33372280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial.
    Faghfouri AH; Khabbazi A; Baradaran B; Khajebishak Y; Baghbani E; Noorolyai S; Rahmani S; Seyyed Shoura SM; Alipour M; Alipour B
    Clin Nutr; 2022 May; 41(5):1083-1092. PubMed ID: 35413570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
    Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
    Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].
    Yong C; Dan L; Chenhong L; Yan S; Jianfei C; Jianlong G
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):127-133. PubMed ID: 30890498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis.
    Dolati S; Ahmadi M; Rikhtegar R; Babaloo Z; Ayromlou H; Aghebati-Maleki L; Nouri M; Yousefi M
    Int Immunopharmacol; 2018 Aug; 61():74-81. PubMed ID: 29852475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial.
    Faghfouri AH; Baradaran B; Khabbazi A; Abdoli Shadbad M; Papi S; Faghfuri E; Khajebishak Y; Rahmani S; Tolou Hayat P; Alipour B
    Int Immunopharmacol; 2022 Aug; 109():108825. PubMed ID: 35561480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.
    Shimizu J; Takai K; Takada E; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Suzuki T; Suzuki N
    Clin Rheumatol; 2016 Jul; 35(7):1857-63. PubMed ID: 25972082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial.
    Vafadar-Afshar G; Rasmi Y; Yaghmaei P; Khadem-Ansari MH; Makhdoomi K; Rasouli J
    Hemodial Int; 2021 Apr; 25(2):232-239. PubMed ID: 33559343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocurcumin modulates Th17 cell responses in moderate and severe COPD patients.
    Mardi A; Abdolmohammadi-Vahid S; Sadeghi SA; Jafarzadeh S; Abbaspour-Aghdam S; Hazrati A; Mikaeili H; Valizadeh H; Sadeghi A; Ahmadi M; Nadiri M
    Heliyon; 2024 May; 10(9):e30025. PubMed ID: 38737273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
    Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Notch pathway activation in Behçet's disease.
    Qi J; Yang Y; Hou S; Qiao Y; Wang Q; Yu H; Zhang Q; Cai T; Kijlstra A; Yang P
    Rheumatology (Oxford); 2014 May; 53(5):810-20. PubMed ID: 24446471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial.
    Ahmadi M; Hajialilo M; Dolati S; Eghbal-Fard S; Heydarlou H; Ghaebi M; Ghassembaglou A; Aghebati-Maleki L; Samadi Kafil H; Kamrani A; Rahnama B; Rikhtegar R; Yousefi M
    J Cell Biochem; 2020 Jan; 121(1):103-110. PubMed ID: 31074089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effect of vitamin D supplementation on Behçet's disease patients: effect on nitric oxide and Th17/Treg cytokines production.
    Oubouchou R; -Djeraba ZAA; Kemikem Y; Otmani F; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):1-10. PubMed ID: 37535442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synbiotic supplementation on regulatory T cells' response in patients with axial spondyloarthritis: a randomized double-masked placebo-controlled trial.
    Khabbazi A; Ahangari Maleki M; Soltani-Zangbar MS; Yousefi M; Malek Mahdavi A
    Food Funct; 2022 Dec; 13(24):12733-12741. PubMed ID: 36409223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.